Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $152.7000 (-2.78%) ($152.7000 - $160.4800) on Mon. Feb. 5, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.77% (three month average) | RSI | 63 | Latest Price | $152.7000(-2.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.9% a day on average for past five trading days. | Weekly Trend | LGND advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.885% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.885% (StdDev 1.77%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
Resistance Level | $155.84 | 5 Day Moving Average | $158.41(-3.6%) | 10 Day Moving Average | $161.71(-5.57%) | 20 Day Moving Average | $155.84(-2.01%) | To recent high | -9.2% | To recent low | 19% | Market Cap | $2.454b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |